This brand name is authorized in Estonia, Ireland, Israel, Lithuania, New Zealand, Poland, Romania, Tunisia

Active ingredients

The drug NOVOMIX-50 contains one active pharmaceutical ingredient (API):

1 Insulin aspart

The blood glucose lowering effect of insulin aspart is due to the facilitated uptake of glucose following binding of insulin to receptors on muscle and fat cells and to the simultaneous inhibition of glucose output from the liver. Insulin aspart produces a more rapid onset of action compared to soluble human insulin, together with a lower glucose concentration, as assessed within the first four hours after a meal. Insulin aspart has a shorter duration of action compared to soluble human insulin after subcutaneous injection.

Read about Insulin aspart

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
NOVOMIX 50 Suspension for injection European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
A10AD05 Insulin aspart A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10A Insulins and analogues → A10AD Insulins and analogues for injection, intermediate-acting combined with fast-acting
Discover more medicines within A10AD05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1242683, 1242694, 1242706, 1242773, 1242784, 1242795
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 6159
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1029900, 1029901, 1029902, 1029903, 1029904, 1029905
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 12537
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100278726, 100312140
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W43547001, W43547002, W43547003, W43549001, W43549002, W43549003
Country: TN Direction de la Pharmacie et du Médicament Identifier(s): 5993083

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.